Literature DB >> 23232831

Cochlear implantation in different health-care systems: disparities between Germany and the United States.

Magnus Teschner1, Colleen Polite, Thomas Lenarz, Lawrence Lustig.   

Abstract

INTRODUCTION: Cochlear implantation is a popular procedure to restore hearing in patients with severe-to-profound hearing loss. Despite the widespread acceptance of the intervention, many variables exist in the evaluation for and implementation of this technology throughout the world. The primary aim of this investigation is to analyze treatment disparities between Germany and the United States in cochlear implantation.
MATERIALS AND METHODS: Cochlear implant recipients in 2 representative cochlear implant centers in the United States and Germany were retrospectively analyzed. Differences in preoperative, perioperative, and postoperative treatment paradigms as well as the disparities in the follow-up were recorded. Objective measures included demographic data, length of hospitalization, minor and major complication rates, and speech scores within the first 3 years. Moreover, a cost analysis comparison between both centers was performed.
RESULTS: A number of differences in treatment were noted between the two centers. The primary difference was that in Germany the procedure was inpatient with an average 4-day hospital stay, whereas in the United States, it was an outpatient procedure. Despite these differences, only small differences were noted in the category of minor complications, and no differences were seen in the category of major complications between the 2 centers. Comparing the results of monosyllabic speech tests, no major differences could be detected. Cost analysis between the 2 centers demonstrates that, whereas in Germany, all charges are covered by the statutory health insurance, in the United States, the reimbursements are significantly lower than the charges. DISCUSSION: Despite differences in the clinical approach to cochlear implants in Germany versus the United States, no significant differences in outcomes were seen in the 2 groups, and the complication rates were nearly identical. Interestingly, although the procedure in Germany is associated with a 4-day hospital stay, the charges for the entire procedure in Germany are approximately ½ as compared with those in the United States, although the actual reimbursement for this procedure may be lower in the United States than in Germany.

Entities:  

Mesh:

Year:  2013        PMID: 23232831     DOI: 10.1097/MAO.0b013e318278bf58

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  6 in total

1.  Clinical Indicators of Admission for Pediatric Cochlear Implant Procedures.

Authors:  Terral A Patel; Shaun A Nguyen; David R White
Journal:  Ann Otol Rhinol Laryngol       Date:  2018-06-01       Impact factor: 1.547

2.  Facial palsy following cochlear implantation.

Authors:  Farid Alzhrani; Thomas Lenarz; Magnus Teschner
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-06-08       Impact factor: 2.503

Review 3.  Structural neuroimaging of the altered brain stemming from pediatric and adolescent hearing loss-Scientific and clinical challenges.

Authors:  J Tilak Ratnanather
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2019-12-04

4.  Subtotal petrosectomy and Codacs™: new possibilities in ears with chronic infection.

Authors:  Burkard Schwab; Eugen Kludt; Hannes Maier; Thomas Lenarz; Magnus Teschner
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-06-20       Impact factor: 2.503

5.  Evaluation of a revised indication for determining adult cochlear implant candidacy.

Authors:  Douglas P Sladen; René H Gifford; David Haynes; David Kelsall; Aaron Benson; Kristen Lewis; Teresa Zwolan; Qian-Jie Fu; Bruce Gantz; Jan Gilden; Brian Westerberg; Cindy Gustin; Lori O'Neil; Colin L Driscoll
Journal:  Laryngoscope       Date:  2017-02-24       Impact factor: 3.325

6.  Preservation of Hearing Following Cochlear Implantation Using Different Steroid Therapy Regimens: A Prospective Clinical Study.

Authors:  Magdalena Beata Skarżyńska; Piotr Henryk Skarżyński; Bartłomiej Król; Magdalena Kozieł; Kamila Osińska; Elżbieta Gos; Henryk Skarżyński
Journal:  Med Sci Monit       Date:  2018-04-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.